303 related articles for article (PubMed ID: 3500393)
1. [Detection of antibodies to the surface (anti-p-41) and nuclear protein (anti-p-24) of the human immunologic deficiency virus (HIV)].
Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
Med Klin (Munich); 1987 Oct; 82(21):723-5, 761. PubMed ID: 3500393
[No Abstract] [Full Text] [Related]
2. Demonstration of antibodies to the surface (anti-p41) and core proteins (anti-p24) of the human immunodeficiency virus (HIV) in individuals positive for anti-HIV.
Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
Klin Wochenschr; 1987 Jul; 65(13):596-9. PubMed ID: 3498088
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
Schulte C; Meurer M; Fröschl M
Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody identifies a highly conserved and immunodominant epitope of the human immunodeficiency virus transmembrane protein.
Papsidero LD; Poiesz BJ; Montagna RA
Hybridoma; 1988 Apr; 7(2):117-28. PubMed ID: 2453451
[TBL] [Abstract][Full Text] [Related]
5. Restricted heterogeneity of antibody to gp120 and p24 in AIDS.
Grimaldi LM; Roos RP; Devare SG; Robey WG; Casey JM; Gurney ME; Apatoff BR; Lazzarin D
J Immunol; 1988 Jul; 141(1):114-7. PubMed ID: 2837506
[TBL] [Abstract][Full Text] [Related]
6. Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.
Norrby E; Biberfeld G; Chiodi F; von Gegerfeldt A; Nauclér A; Parks E; Lerner R
Nature; 1987 Sep 17-23; 329(6136):248-50. PubMed ID: 3041232
[TBL] [Abstract][Full Text] [Related]
7. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
[TBL] [Abstract][Full Text] [Related]
8. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays.
Resnick L; Shapshak P
Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005
[TBL] [Abstract][Full Text] [Related]
9. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
Klasse PJ; Pipkorn R; Blomberg J
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
[TBL] [Abstract][Full Text] [Related]
10. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide.
Zhou EM; Chanh TC; Dreesman GR; Kanda P; Kennedy RC
J Immunol; 1987 Nov; 139(9):2950-6. PubMed ID: 3668251
[TBL] [Abstract][Full Text] [Related]
11. Role of HTLV III/LAV envelope protein.
Bicker U
Nature; 1986 Nov 27-Dec 3; 324(6095):307. PubMed ID: 3466037
[No Abstract] [Full Text] [Related]
12. Detection and characterization of circulating immune complexes in HIV-related diseases.
Carini C; D'Amelio R; Mezzaroma I; Aiuti F
Diagn Clin Immunol; 1987; 5(3):135-9. PubMed ID: 3480082
[TBL] [Abstract][Full Text] [Related]
13. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
[TBL] [Abstract][Full Text] [Related]
14. Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.
Zweig M; Showalter SD; Bladen SV; Gilden RV; Arthur LO; Robey WG; Nara PL; Fischinger PJ
AIDS Res Hum Retroviruses; 1988 Feb; 4(1):51-62. PubMed ID: 3259140
[TBL] [Abstract][Full Text] [Related]
15. Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.
Ameisen JC; Guy B; Chamaret S; Loche M; Mach B; Tartar A; Mouton Y; Capron A
N Engl J Med; 1989 Jan; 320(4):251-2. PubMed ID: 2783476
[No Abstract] [Full Text] [Related]
16. Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein.
Chiodi F; von Gegerfeldt A; Albert J; Fenyö EM; Gaines H; von Sydow M; Biberfeld G; Parks E; Norrby E
J Med Virol; 1987 Sep; 23(1):1-9. PubMed ID: 3500271
[TBL] [Abstract][Full Text] [Related]
17. Prediction of HIV vaccine.
Robson B; Fishleigh RV; Morrison CA
Nature; 1987 Jan 29-Feb 4; 325(6103):395. PubMed ID: 3468356
[No Abstract] [Full Text] [Related]
18. IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans.
Goudsmit J; Smit L; Krone WJ; Bakker M; van der Noordaa J; Gibbs CJ; Epstein LG; Gajdusek DC
J Infect Dis; 1987 Feb; 155(2):327-31. PubMed ID: 3492573
[No Abstract] [Full Text] [Related]
19. Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections.
Hofbauer JM; Schulz TF; Hengster P; Larcher C; Zangerle R; Kofler H; Fritsch P; Wachter H; Dierich MP
J Clin Microbiol; 1988 Jan; 26(1):116-20. PubMed ID: 3277988
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.
Ranki A; Weiss SH; Valle SL; Antonen J; Krohn KJ
Clin Exp Immunol; 1987 Aug; 69(2):231-9. PubMed ID: 3652531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
